|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/48 | |||
| A61K 31/513 |
| (11) | Number of the document | 1819323 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05852790.4 |
| Date of filing the European patent application | 2005-12-02 | |
| (97) | Date of publication of the European application | 2007-08-22 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/043675 |
| Date | 2005-12-02 |
| (87) | Number | WO 2006/060681 |
| Date | 2006-06-08 |
| (30) | Number | Date | Country code |
| 632859 P | 2004-12-03 | US |
| (72) |
CRUANES, Maria, T., US
XU, Wei, US
ARTINO, Laura, M., US
ZHU, Honggang, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-NUCLEATING AGENT |
| PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-NUCLEATING AGENT |